Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

Products and Business Services
Group A, C Meningococcal Polysaccharide-Conjugate Vaccine
Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

Information

MeningACon is the first approved product in China,more than 36 million doses has been used.
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
China
Main Categories
APIs (Active Pharmaceutical Ingredients)
Chongqing Zhifei Biological Products Co., Ltd.3.A14Chongqing Zhifei Biological Products Co., Ltd. is the largest listed vaccine company in China，which has its presence in biological product industry in 2002.The Company achieved an operating income of RMB38.3 billion In 2022 with the support of its nearly 7000 employees.As a high-tech biological enterprise integrating the R&D, production, marketing, distribution as well as import & export, Zhifei mainly engages in the production of vaccines for human use. Our research channels cover many indications extensively: like COVID-19, tuberculosis, meningitis, etc.

Join the event!

See all the content and easy-to-use features by logging in or registering!